10% OID CONVERTIBLE Delayed draw DEBENTUREBiovie Inc. • September 25th, 2019 • Pharmaceutical preparations • New York
THIS 10% ORIGINAL ISSUE DISCOUNT CONVERTIBLE DEBENTURE is a series of duly authorized and validly issued 10% OID Convertible Delayed Draw Debentures of BioVie Inc., a Nevada corporation, (the “Company”), having its principal place of business at 2120 Colorado Boulevard, Suite 230, Los Angeles, California, designated as its 10% OID Convertible Delayed Draw Debenture (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
COMMON STOCK PURCHASE WARRANTBiovie Inc. • September 25th, 2019 • Pharmaceutical preparations • New York
This Warrant has been issued pursuant to the terms of that certain Securities Purchase Agreement, dated as of September 20, 2019 (the “Purchase Agreement”), by and among the Company and Holder and the other Purchasers party thereto. Capitalized terms not defined herein shall have the meanings given to them in the Purchase Agreement. As used herein the following terms, unless the context otherwise requires, have the following respective meanings:
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 25th, 2019 • Biovie Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of September 24, 2019, between BioVie Inc., a Nevada corporation (the “Company”) and Acuitas Group Holdings, LLC (“Acuitas” or the “Purchaser”).
